In this certified on-demand webcast, experts discuss the management of CLL/SLL therapy from frontline treatment to relapsed/refractory disease based on evidence from recent clinical trials and current NCCN guidelines as well as future directions to personalize and optimize patient care.
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with chronic lymphocytic leukemia (CLL).

The goal of this program is to improve the knowledge and competence of clinicians to implement best practices in the treatment of CLL.

 

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

This activity will help you navigate the unique complexities of managing Richter transformation, while keeping you up to date on the latest advances and emerging therapies. You will gain practical insights to identify the right patients for novel treatments, integrate new approaches into care, and recognize when referral to clinical trials can offer the best outcomes.
Join us for this dynamic, case-based, live symposium in collaboration with the NCCN to hear from an expert panel on current recommendations and emerging strategies for treating patients with CLL.
The goal of this activity is to improve learners’ knowledge, competence, and confidence to integrate new and emerging therapies into practice to improve clinical outcomes in patients with chronic lymphocytic leukemia / small lymphocytic lymphoma.
The goal of this activity is to improve learners’ knowledge, competence, and confidence to integrate new and emerging therapies into practice to improve clinical outcomes in patients with chronic lymphocytic leukemia / small lymphocytic lymphoma.

The prognostic significance of molecular and cytogenetic variables vary depending on the treatment regimens and clinical outcomes being evaluated.

The goal of this program is to improve the knowledge, confidence, and competence of learners in the potential clinical applications of guideline-recommended therapy for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Pages

Subscribe to RSS - Chronic Lymphocytic Leukemia